Multicancer early detection feasible for outpatients
A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at
Updated on: December 21,2023
Multicancer early detection feasible for outpatients
A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at
Updated on:December 21,2023
